News

Wednesday April 29, 2020

29 Apr 2020 – Audited results for the year ended 31 December 2019 and clinical dev...

Destiny Pharma plc (“Destiny Pharma” or “the Company”) Audited results for the year ended 31 December 2019 and clinical development update Company funded through to Q4 2021 Patient recruitment for […]

Wednesday April 8, 2020

08 Apr 2020 – Destiny Pharma featured in Endpoints News

Destiny Pharma CEO Neil Clark has been interviewed for an Endpoints News article published on the 7th April discussing what the coronavirus pandemic means for the field of antibiotics. To […]

Thursday April 2, 2020

02 Apr 2020 – Antibiotic resistance could lead to more covid-19 deaths

Antibiotic resistance could lead to more covid-19 deaths. Report highlights need for new anti-infectives to fight associated bacterial infections.  Click here to read the report.